Agios Pharma (AGIO) Tops Q3 EPS by 12c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.78), $0.12 better than the analyst estimate of ($1.90). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $10.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Strategy (MSTR) call put ratio 1.2 calls to 1 put as share price below $100
• EQT Corp. (EQT) PT Lowered to $65 at Truist Securities